ESC Premium Access

Circulating CD4+T/Methylation Signatures of Network-oriented SOCS3, ITGAL, NFIC, NCOR2, PGK1 Genes Associate with Hemodynamics in Pulmonary Arterial Hypertension Patients

Presentation

About the speaker

Doctor Giuditta Benincasa

University of Campania Luigi Vanvitell, Naples (Italy)
0 follower

73 more presentations in this session

The novel noninvasive method for prediction of long-term specific therapy efficacy in patients with IPAH and inoperable CTEPH

Speaker: Mrs I. Lyapina (Kemerovo, RU)

Thumbnail

Early and long term prognostic accuracy of 4 acute pulmonary embolism mortality risk scores

Speaker: Doctor L. Oliveira (Ponta Delgada, PT)

Thumbnail

Novel genetic and molecular pathways in pulmonary arterial hypertension associated with connective tissue disease

Speaker: Doctor I. Hernandez Gonzalez (Valladolid, ES)

Thumbnail

Role of echocardiography to avoid misclassification of pulmonary hypertension associated with left heart disease as precapillary pulmonary hypertension.

Speaker: Assistant Professor J. Grignola Rial (Montevideo, UY)

Thumbnail

Survival of patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension listed for lung transplantation

Speaker: Doctor I. Magnani (Bologna, IT)

Thumbnail

Access the full session

Pulmonary circulation, pulmonary embolism, right heart failure e-posters

Speakers: Doctor G. Benincasa, Mrs I. Lyapina, Doctor L. Oliveira, Doctor I. Hernandez Gonzalez, Assistant Professor J. Grignola Rial...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

Long-term outcomes in PAH: Optimised approach to achieve the best outcomes.

27 August 2021

ESC Premium Access

Real-world, very long-term follow up survival of incident patients with pulmonary hypertension

27 August 2021

ESC Premium Access

DYNAMIC - Riociguat in patients with pulmonary hypertension and heart failure with preserved ejection fraction

27 August 2021

This platform is supported by

logo Novo Nordisk